[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-338407-105":3,"detail-sidebar-cat-0-en-105":73,"doc-detail-338407-en":122},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":66,"head_meta":68,"extra_data":70,"updated_unix":72},105,"en","dormancy-inducing-3d-engineered-matrix-uncovers-mechanosensitive-and-drug-protective-fhl2-p21-signaling-axis","Dormancy-inducing 3D engineered matrix uncovers mechanosensitive and drug-protective FHL2-p21 signaling axis","","Cellular dormancy drives drug resistance and late relapse, creating a need for in vitro models that reproduce dormant minimal residual cancer states for drug discovery. This work develops dormancy-inducing 3D engineered matrices that impose mechanical confinement, causing growth arrest and chemotherapy survival. Dormant solitary cells show a characteristic P-ERKlow:P-p38high ratio with Ki67− expression, linked to stiffness-dependent nuclear FHL2 localization, triggering p53-independent p21Cip1/Waf1 nuclear upregulation. FHL2 downregulation increases chemotherapy sensitivity, enabling systematic screening for agents targeting relapsing dormant cancer cells.",{"@graph":14,"@context":65},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/dormancy-inducing-3d-engineered-matrix-uncovers-mechanosensitive-and-drug-protective-fhl2-p21-signaling-axis/338407/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/dormancy-inducing-3d-engineered-matrix-uncovers-mechanosensitive-and-drug-protective-fhl2-p21-signaling-axis/338407.png","ImageObject",300,407,{"name":42,"@type":43},"Eden","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-15","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59],{"name":60,"@type":61,"acceptedAnswer":62},"How does FHL2 down-regulation affect chemotherapy response?","Question",{"text":63,"@type":64},"Cells in the dormancy-inducing matrix become more sensitive to chemotherapy when FHL2 is down-regulated, supporting a resistance-causing role for the pathway.","Answer","https://schema.org",{"og:url":32,"og:type":67,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":69,"canonical":32},"index,follow",{"doc_id":71,"site_id":7},338407,1790546244,{"code":4,"msg":74,"data":75},"success",[76,80,84,88,93,98,103,106,111,114,118],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":77,"show_sort_weight":78,"slug":79},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":81,"show_sort_weight":82,"slug":83},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Exam",70,"exam",{"id":89,"doc_module":4,"doc_module_name":25,"category_name":90,"show_sort_weight":91,"slug":92},5,"Comic",60,"comic",{"id":94,"doc_module":4,"doc_module_name":25,"category_name":95,"show_sort_weight":96,"slug":97},6,"Technology",50,"technology",{"id":99,"doc_module":4,"doc_module_name":25,"category_name":100,"show_sort_weight":101,"slug":102},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":104,"slug":105},30,"research-report",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},9,"Religion & Spirituality",20,"religion-spirituality",{"id":109,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":109,"slug":113},"World Cup","world-cup",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":115,"slug":117},10,"Lifestyle","lifestyle",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":89,"slug":121},19,"General","general",{"code":4,"msg":74,"data":123},{"doc_id":71,"user_id":124,"nickname":42,"user_avatar":125,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":131,"language":132,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":12,"update_tm":136,"read_time":137,"preview_page_count":33,"preview_urls":138},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","APPLIED SCIENCES AND ENGINEERING  \nDormancy-inducing 3D engineered matrix uncovers mechanosensitive and drug-protective FHL2-p21 signaling axis  \nSadra Bakhshandeh1†, Unai Heras2,3†, Hubert M. Taïeb1, Adithi R. Varadarajan4, Susanna M. Lissek5, Sarah M. Hücker4, Xin Lu4, Daniela S. Garske1, Sarah A. E. Young1,  \nAndrea Abaurrea6, Maria M Caffarel6,7, Ana Riestra8,9, Paloma Bragado10,11, Jörg Contzen12,13,14, Manfred Gossen13,14, Stefan Kirsch4, Jens Warfsmann4, Kamran Honarnejad4,  \nChristoph A. Klein4,5, Amaia Cipitria1,2,7*  \nSolid cancers frequently relapse with distant metastasis, despite local and systemic treatment. Cellular dormancy has been identified as an important mechanism underlying drug resistance enabling late relapse. Therefore, relapse from invisible, minimal residual cancer of seemingly disease-free patients call for in vitro models of dormant cells suited for drug discovery. Here, we explore dormancy-inducing 3D engineered matrices, which generate mechanical confinement and induce growth arrest and survival against chemotherapy in cancer cells. We characterized the dormant phenotype of solitary cells by P-ERKlow:P-p38high dormancy signaling ratio, along with Ki67 − expression. As underlying mechanism, we identified stiffness-dependent nuclear localization of the four-and-a-half LIM domain 2 (FHL2) protein, leading to p53-independent high p21Cip1/Waf1 nuclear expression, validated in murine and human tissue. Suggestive of a resistance-causing role, cells in the dormancy-inducing matrix became sensitive against chemotherapy upon FHL2 down-regulation. Thus, our biomaterial-based approach will enable systematic screens for previously unidentified compounds suited to eradicate potentially relapsing dormant cancer cells.  \ncopyright © 2024 the Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S.  \nGovernment Works. distributed under a creative commons Attribution Noncommercial license 4.0 (cc BY-Nc) .  \nINTRODUCTION  \nMost cancer-associated deaths are due to metastasis, with eventual relapses spanning from years to decades despite adjuvant therapies (1, 2). Patients with estrogen receptor–negative (ER − ) breast cancer are often diagnosed with metastasis or relapse within the first 5 years, whereas patients with ER+ breast cancer continue to relapse beyond 8 years after surgery (1). Cancer dormancy has been described as oneof the main mechanisms of evasion underlying late relapse ( 1, 3) . Because of its asymptomatic nature, it poses substantial technical challenges for the identification, isolation, and investigation of disseminated cancer cells (DCCs) in patients (1, 4) .  \nIn solid epithelial cancer, detection of DCCs in asymptomatic patients without metastases (M0) usually relies on antibodies against proliferation markers such as Ki67 . These markers, defined decades  \n1department of Biomaterials, Max Planck institute of colloids and interfaces, Potsdam, Germany. 2Group of Bioengineering in Regeneration and cancer, Biogipuzkoa health Research institute, San Sebastian, Spain. 3department of cell Biology and histology, Faculty of Medicine and Nursing, University of the Basque country UPv/ehU, leioa, Spain. 4division of Personalizedtumor therapy, Fraunhofer institute for toxicology and experimental Medicine, Regensburg, Germany. 5experimental Medicine and therapy Research, University of Regensburg, Regensburg, Germany. 6Group of Breast cancer, Biogipuzkoa health Research institute, San Sebastian, Spain. 7iKeRBASQUe, Basque Foundation for Science, Bilbao, Spain. 8department of Pharmacy, Fundación Onkologikoa Fundazioa, San Sebastian, Spain. 9department of Medicine, University of deusto, Bilbao, Spain. 10department of Biochemistry and Molecular Biology, Faculty of Pharmacy, complutense University of Madrid, Madrid, Spain. 11health Research institute of the hospital clínico San carlos, Madrid, Spain. 12department of experimental Neurology, ","cbCaif9GlJZB4A7s","https://ap.wps.com/l/cbCaif9GlJZB4A7s","pdf",2551302,18,"English","# Introduction\n## Cancer dormancy, metastasis, and late relapse\n## Limits of existing DCC detection and animal models","[{\"question\":\"How does FHL2 down-regulation affect chemotherapy response?\",\"answer\":\"Cells in the dormancy-inducing matrix become more sensitive to chemotherapy when FHL2 is down-regulated, supporting a resistance-causing role for the pathway.\"}]","Dormancy-inducing 3D engineered matrix uncovers mechanosensitive and drug-protective FHL2-p21 signaling axis | PDF",1790023517,45,[139,143,147,151],{"page_no":22,"url":140,"width":141,"height":142},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/42552bfc9bc1bb24a060fdcf5ad78463.webp",983,1250,{"page_no":26,"url":144,"width":145,"height":146},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a1506e5c852a34dc67503e191308d12e.webp",982,1249,{"page_no":30,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c1590efb1090ae6905199e073d0ef47.webp",981,1248,{"page_no":33,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7de4273bfd890038386c4bccca551feb.webp",980,1247]